BRIACELL THERAPEUTICS CORP. Proceeds from Issuance or Sale of Equity
BRIACELL THERAPEUTICS CORP. (BCTX) reported Proceeds from Issuance or Sale of Equity of $30.00 million for the 1-month period ending 2026-01-31, per its 10-Q filed 2026-06-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-06-09
| Period end | Proceeds from Issuance or Sale of Equity 1 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|
| 2026-01-31 | $30.00M 10-Q · filed 2026-06-09 | |
| 2025-07-31 | $50.90M 10-Q · filed 2026-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |